Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?
Fırat Duru(University of Malta)
Cited by 56
Related Papers
First magnetic resonance imaging-guided cardiac radioablation of sustained ventricular tachycardia
|Radiotherapy and Oncology|2020|86
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy
|Circulation Arrhythmia and Electrophysiology|2020|46
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
|Clinical and Translational Medicine|2021|22
Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry
|Journal of the American Heart Association|2023|17
Use of the wearable cardioverter-defibrillator – the Swiss experience
|Swiss Medical Weekly|2020|14